Drugs / TAK-671
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04464460 | Sep → Oct 2020 | COVID-19 | Takeda | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-671 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04464460 ↗ |
| Route | Intravenous | “TAK-671 intravenous infusion.” NCT04464460 ↗ |